Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Profound Medical (PROF)

Profound Medical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PROF
DateTimeSourceHeadlineSymbolCompany
09/05/202421:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
09/05/202421:05GlobeNewswire Inc.Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue GuidanceNASDAQ:PROFProfound Medical Corporation
06/05/202421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PROFProfound Medical Corporation
06/05/202421:15GlobeNewswire Inc.Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease SpectrumNASDAQ:PROFProfound Medical Corporation
22/04/202421:15GlobeNewswire Inc.Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
09/04/202412:45GlobeNewswire Inc.Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:PROFProfound Medical Corporation
07/03/202421:05GlobeNewswire Inc.Profound Medical Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
04/03/202421:30GlobeNewswire Inc.Profound Medical to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
27/02/202412:45GlobeNewswire Inc.Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA ProcedureNASDAQ:PROFProfound Medical Corporation
15/02/202421:30GlobeNewswire Inc.Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
16/01/202421:30GlobeNewswire Inc.Profound Medical Announces Non-Brokered Private PlacementNASDAQ:PROFProfound Medical Corporation
03/01/202421:15GlobeNewswire Inc.Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 RevenuesNASDAQ:PROFProfound Medical Corporation
28/12/202303:40GlobeNewswire Inc.Profound Medical Announces Pricing of US$20 Million Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
27/12/202321:15GlobeNewswire Inc.Profound Medical Announces Proposed Public Offering of Common SharesNASDAQ:PROFProfound Medical Corporation
08/11/202312:45GlobeNewswire Inc.Profound Medical to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
03/11/202312:00GlobeNewswire Inc.Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC SettingNASDAQ:PROFProfound Medical Corporation
02/11/202320:05GlobeNewswire Inc.Profound Medical Announces Third Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
19/10/202321:30GlobeNewswire Inc.Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
10/10/202321:30GlobeNewswire Inc.Profound Medical 2023 Virtual Analyst & Investor Day AgendaNASDAQ:PROFProfound Medical Corporation
25/09/202321:05GlobeNewswire Inc.Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal BoostNASDAQ:PROFProfound Medical Corporation
21/09/202313:00GlobeNewswire Inc.Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13NASDAQ:PROFProfound Medical Corporation
19/09/202321:45GlobeNewswire Inc.Profound Medical to Participate in the 2023 Cantor Global Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
07/09/202300:23GlobeNewswire Inc.Profound Medical Announces At-the-Market Offering of up to US$30,000,000NASDAQ:PROFProfound Medical Corporation
09/08/202321:05GlobeNewswire Inc.Profound Medical Announces Second Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
02/08/202321:30GlobeNewswire Inc.Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to FollowNASDAQ:PROFProfound Medical Corporation
02/06/202318:40GlobeNewswire Inc.Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate DiseasesNASDAQ:PROFProfound Medical Corporation
30/05/202313:00GlobeNewswire Inc.Profound Medical Announces Upcoming Investor EventsNASDAQ:PROFProfound Medical Corporation
18/05/202313:00GlobeNewswire Inc.Profound Medical to Participate in A.G.P.’s Virtual Healthcare ConferenceNASDAQ:PROFProfound Medical Corporation
17/05/202321:15GlobeNewswire Inc.Profound Medical Annual and Special Meeting of Shareholders Voting ResultsNASDAQ:PROFProfound Medical Corporation
10/05/202321:05GlobeNewswire Inc.Profound Medical Announces First Quarter 2023 Financial ResultsNASDAQ:PROFProfound Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:PROF